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THE LEUKEMOGENIC ACTION OF ESTROGENS IN
HYBRID MICE*
W. U. GARDNER AND T. F. DOUGHERTY
The estrogens, a group of substances some of which are produced
within the body, act much like the carcinogenic hydrocarbons under
some conditions. At least five types of tumor appear among estro-
gen-treated mice; namely, mammary, uterine, hypophyseal, testic-
ular, and lymphoid.8'" Other factors or influences are now known
to be necessary for the realization of all of the above types of neo-
plasia in estrogen-treated mice except those of the uterine cervix.
The additional factors or influences are those transmitted by parent
or parents to their young; in other words, the tumors are strain-
limited in their appearance. However, of the tumors mentioned
only those of the mammary glands may appear frequently among
the untreated control animals of the groups being considered at this
time.24 The intrinsic humoral environments in multiparous mice of
the susceptible groups are adequate to provoke mammary neoplasia.
The tumors of the other glands or tissues require, for their instiga-
tion, a more drastic or a different type of stimulation; hence their
infrequent spontaneous appearance among the animals studied here.
The carcinogenic hydrocarbons were thought at one time to pro-
voke tumors only in the immediately adjacent or subjacent tissues.
It is now known, however, thatmammary,4' 26 pulmonary,2' hepatic,25
orlymphoid5' 19, 20, 23 tumors may occur among mice given subcutane-
ous or percutaneous applications of carcinogenic hydrocarbons.
Interestingly, transmitted or inherited factors also determine the
nature of the response in animals given carcinogenic hydrocarbons.
Carcinogens induce lymphoid tumors in mice of some strains but
not in mice of other strains. In mice of strains that show a tendency
to acquire lymphoid tumors spontaneously the carcinogen may
increase the incidence or decrease the average age of onset of the
disease.
The mice of strains which show a high incidence of lymphoid
tumors subsequent to estrogen treatment may not acquire such
* From the Department of Anatomy, Yale University School of Medicine.
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tumors when subjected to carcinogens.12 19 More than one etiologi-
cal agent may exist for the same type of tumor in animals of different
genetic origins.
Earlier observations showed that mice from 3 of 7 inbred strains
had high incidences of lymphoid tumors when estrogens were
injected.12 Very few estrogen-treated animals from two strains
showed lymphoid tumors. For the present experiments hybrid mice
were obtained by mating males and females of six different inbred
strains (table 1) todetermine the extent to which the susceptibility to
the estrogen induction of lymphoid tumors might be transmitted.
TABLE I
LYMPHOID TUMORS AMONG CONTROL AND ESTROGEN-TREATED MICE OF
6 DIFFERENT STRAINS
Controls Estrogen-treated
Number of Numberof Percentage Number of Number of Percenttage
Strain animals tumors of tumors animals tunors of tumors
GH 481 5 1 747 109 14.4
CBA 62 2 3.2 445 67 15.1
PM 58 0 0 143 22 15.4
A 82 0 0 94 3 2.1
C57 59 3 5.0 170 3 1.8
JK 37 1 2.7 64 3 4.7
Materials and methods
Mice of 6 inbred strains C3H, A, CBA, C,7, JK, and PM*) were used
as parents for the first generation hybrid mice used for these experiments.
Eight pairs of reciprocal matings between males and females of these strains
were made as shown in table 2.
Approximately 50 hybrid mice of each group were kept as untreated
controls. The control males and females were caged together and the litters
were removed at birth so that the females were almost continually pregnant
during their sexually active life.
The estrogen-treated mice were divided into groups each of which was
* The mice of the A, C8H, CBA, C57, and JK strains were supplied by Dr.
L. C. Strong or raised from animals obtained from his colony. The original pair
of mice of the PM group was obtained from Dr. H. B. Andervont. The mice of
the latter strain were frequently sterile, their genital tracts failed to develop normally,
and the stock could not be maintained.
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TABLE 2
THE ORIGIN OF THE MICE USED TO DETERMINE THE INFLUENCE OF GENETIC OR
MATERNALLY TRANSMITTED FACTORS OR INFLUENCES ON ESTROGEN-INDUCED
LYMPHOID TUMORS
Strainoforigin Designation of
hybrid group Maternal Paternal
AC1 A CH
AC2 CH A
A,n A C67
A72 C7 A
AB1 A CBA
AB2 CBA A
JA1 A JK
JA2 JK A
HC1 C7 CH
HC2 QH CG7
PC1 GH PM
PC2 PM C3H
jc1 GH JK
JC2 JK GH
CCQ C7 CBA
CC2 CBA C7
given one of several different estrogens or doses of estrogens. The'estrogens,*
estradiol benzoate, stilbestrol, estrone, and estradiol dipropionate were admin-
istered in solution in sesame oil or as pellets of the pure crystalline hormone,
or as pellets of the hormone mixed with cholesterol. The weekly subcu-
taneous doses of estradiol benzoate were 16.6 ,ug. and 25 ,ug.; of stilbestrol,
250 Jug.; of estradiol dipropionate, 10 ,ug., 25 pug., or 50 /-&g. The pellets
of estrone used weighed from 1.2 to 7 mg. They were weighed before they
were implanted subcutaneously through a trocar and again weighed after they
were removed at the time of autopsy. The pellets containing stilbestrol con-
tained either 3 parts of cholesterol to 1 part of stilbestrol or 9 parts of cho-
lesterol to 1 part of stilbestrol. The stilbestrol-cholesterol pellets were made
by compression of the mixed and powdered crystals. The pellets implanted
weighed from 4 to 8 mg. and were weighed again after their removal at
autopsy.
* The estradiol benzoate was supplied by the Schering Corporation by Dr. E.
Schwenk; the estradiol dipropionate and estrone by Ciba Pharmaceutical Products;
and the stilbestrol by the E. R. Squibb & Sons Company. The hormones were
dissolved in oil so that the weekly dose was contained in 0.05 cc.
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The estrogens were usually first administered when the animals were
30 to 40 days of age. The mice were observed until death, until tumors
appeared, or until their general condition had deteriorated indicating the
imminence of death. All animals were autopsied. If gross evidences of
tumors were apparent, tissues were saved for histological examination after
fixation in Bouin's fluid and staining with hematoxylin and triosin. The
tissues usually studied in such animals were mediastinal masses of lymphoid
tissue, the livers, spleens, kidneys, and lymph nodes. Occasionally infiltrations
of malignant lymphocytes were also observed in the genital tissues, mam-
mary glands, adrenal glands, or other tissues, which were also examined
routinely in connection with other phases of this study.
The mice were kept in the same room of an air-conditioned laboratory.
They were fed Purina fox chow and water.
Litter-mates were used in both the control and experimental groups in so
far as possible. A minimal number of breeding animals was used to supply
the first generation hybrid offspring. A large number of progeny of one pair
of breeders was available in numerous instances.
TABLE 3
INCIDENCE OF LYMPHOID TUMORS AMONG F1 HYBRIDS
Controls Estrogen-treated
A
A
Hybrid Nutnberof Numberof Percentage Numberof Numberof Percentage
group animals tumors oftumors animals tumors of tumors
AC, 48 1 2.0 107 8 8
AC2 49 1 2.0 114 12 10
An 52 6 11.5 107 9 10
An 50 10 2J).0 99 7 7
AB1 49 0 0 93 3 3
AB2 43 0 0 73 7 10
JA1 41 1 0 66 0 0
(myeloid)
JA2 50 8 16 98 0 0
HC1 52 0 0 105 13 12
HC2 53 1 2 115 15 13
PC1 49 0 0 86 33 40
PCQ 46 0 0 81 36 45
JC1 49 1 2 60 1 2
JC2 46 1 2 94 8 8
CC. 38 2 5 53 5 10
CCQ 24 2 8 52 7 14
Total 739 , 34 4.5 1403 165 12
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Observations
Lymphoid tumors were found in 165 of the 1403 estrogen-
treated hybrid mice, or in approximately 12 per cent of the animals
(table 3). The total incidence of tumors* was similar to that
observed among the estrogen-treated mice of the pure strains from
which the hybrid mice were derived. The number of tumors among
the untreated mice (4.5 per cent) was greater than among the control
mice of the pure strains (1.34 per cent). Thirty-three of the 739
untreated hybrid mice had lymphoid tumors at death. The rela-
tively high incidence among the control animals resulted from the
frequent appearance of tumors among three groups, namely, the
A71, A72, and JA2 groups (table 3). Twenty-four of the 33 animals
dying with tumors were among the 152 mice of these three groups,
whereas only 9 tumors (1.5 per cent) were found among the 576
mice of the other 13 groups, an incidence comparable to that of the
untreated mice of the parental strains.
Mice from the C3H, CBA, and PM strains showed high inci-
dences of lymphoid tumors when subjected to high doses of estro-
gens for 10 weeks or more, whereas estrogen-treated mice of the
A, JK, and C57 strains showed little or no leukemic response
(table 1, Chart I). The incidence of spontaneous lymphoid neo-
plasia among these strains was also very low (0 to 5 per cent), but
it was highest in the C57 strain.
When F1 hybrid mice of two strains (C3H x PM) that showed
a marked increase ofleukemia subsequent to estrogen treatment were
treated in the same manner as animals of their parental strains the
incidence of tumors was very high, reaching 40 and 45 per cent
(tables 3 and 4). The incidence of lymphoid neoplasia was greater
than it had been in either of the parental strains and it was similar in
bo-th of the reciprocal crosses of PC groups, namely, the PC1 and
PC2 groups. The absence of tumors among the untreated control
mice of these groups contrasts with the high incidence among the
treated mice, and again the observations were similar to those made
upon the mice of the parental strains.
Five pairs of groups of hybrid mice were obtained by mating
animals of one strain which showed a high incidence of leukemia
*The word "tumor" used in this paper, unless otherwise indicated, refers to
malignant lymphoid tumors of all types, that is, lymphatic leukemia, lymphosarcoma,
etc.
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subsequent to estrogen treatment and one which did not. The
incidences of tumors were approximately 9, 6, 12, 5, and 12 per
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CHART I. The incidence of lymphoid tumors among estrogen-treated and control mice
of 6 inbred strains and of 16 first-generation hybrid groups derived from reciprocal crosses
of males and females of these strains. The sections of the chart designated A, B, and C
present the incidence of tumors among the offspring of two strains susceptible to estrogen-
induced lymphomas, one susceptible and one resistant strain, and two resistant strains,
respectively.
cent for the mice of the AC, AB, HC, JC, and CC groups, respec-
tively (tables 3 and 4).
The mice of the C3H and CBA strains contributed the suscepti-
bility to lymphoid tumors in these groups and animals of the A,
C57, or JK strains were the non-susceptible parents (tables 1 and 2).
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The incidences of lymphoid tumors were lower among the mice of
these groups than in the group that had both parents from mice of
the susceptible strains (tables 3 and 4). Four of the 5 groups of
hybrids showed slightly higher incidences of lymphoid tumors when
the mnaternal parents were from the more responsive C3H or CBA
strains. Eight per cent of the AC1 mice died with lymphoid neo-
plasia in contrast to 10 per cent of the AC2 animals, although the
latter lived, on the average, 34 days less than the former (tables
3 and 5). The lymphoid tumors also appeared nearly 50 days
earlier in the mice of the AC2 group. Also among the AB, HC, and
CC groups the incidence of tumors was highest when the mice of the
CBA or C3H strains were the maternal parents (tables 3, 4, and 5).
The average periocds of survival of the mice with maternal parents
of the tumor-susceptible groups were again shorter than those of the
members of the reciprocal pairs with the A or C57 mothers. On the
other hand, the hybrid mice of the JC groups had the highest inci-
dence of lymphoid tumors when mice of the JK strain, which were
not susceptible to estrogen-induced leukemia, were the maternal
parents (tables 3 and 4). The tumors occurred in older animals
in this group and at an average age of 453 days (table 5).
The hybrid mice obtained by mating animals from two strains
which showed little or no increase in the incidence of leukemia sub-
sequent to estrogen treatment differed greatly in their leukemic
response to estrogen. Approximately 9 per cent of the A7 and none
of the JA groups had lymphoid tumors (tables 3 and 4). On the
other hand, from 11 to 20 per cent of the untreated controls died
with lymphoid tumors (table 3). It is of interest that the highest
incidences of tumors which appeared among the control mice were in
the groups least responsive to tumor induction subsequent to estrogen
treatment.
The age of the animals as related to the appearance of leukemia
Among the estrogen-treated mice the average ages at which
lymphoid tumors appeared corresponded roughly to the average
age of survival of all the mice among the several groups (table 5).
The youngest mouse to show a lymphoid tumor was 148 days old
and from the HCO group. The average ages at the time leukemia
appeared among the mice of the different groups ranged from 266
days to 453 days. The average ages at death of all of the mice from
each of the 16 groups ranged from 254 to 392 days.
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The untreated control mice of the 16 groups lived, on the aver-
age, from 291 to 717 days and the average ages at which lymphoid
tumors appeared among the mice of these groups ranged from 462
to 863 days, in most instances well beyond the average ages at death
of all of the animals in the groups (table 5). The average ages of
the mice of 15 of the 16 control groups exceeded those of the estro-
gen-treated mice. The untreated mice acquired tumors when they
were approximately twice as old as the animals in which such neo-
plasia appeared following estrogen treatment.
The average survivals of the two groups of control mice of each
ofthe A7, AB, JA, HC, PC, and JC groups differed from each other.
This was due to the high incidence of mammary tumors among the
mice with the maternal parents of the A or C3H strains and the
relative infrequency or late appearance of mammary tumors in the
reciprocal hybrids with maternal parents of the JK, C57, PM, and
CBA strains.
The influence of the effective dose of estrogen upon the incidence
of tumors
"
The highest incidence of lymphoid tumors occurred among the
mice which had received pellets of estrone or of stilbestrol and cho-
lesterol (tables 4 and 6). Of the mice of these groups 18 and 36
per cent died with tumors. The comparatively high incidence of
tumors among the mice which received the pellets of stilbestrol and
cholesterol might in part be attributed to thelarge numberof animals
in the PC groups subjected to such treatment. However, with the
exception of the JA groups, all groups that received this treatment
showed lymphoid tumors. The lowest incidence of tumors occurred
among the mice that received weekly injections of 250 Vg. of stilbes-
trol. Although this is a large dose in terms of mouse units it is a
relatively small effective dose when administered in one injection
weekly. The mice receiving the oily solution of stilbestrol tolerated
the treatment well.
The incidences of tumors among the two groups of mice receiv-
ing estradiol benzoate and the groups that received the larger doses
of estradiol dipropionate were moderately high.
The above observations reveal that high effective doses of estro-
gen, especially continuous sources of hormone as provided by pellets,
are most frequentlyaccompanied by the appearance oflymphoid neo-
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TABLE 6
TOTAL NUMBER AND PER CENT OF MICE, SUBJECTED TO THE DIFFERENT DOSES OF
ESTROGEN, THAT DIED WITH LYMPHOID TUMORS
Number
Weekly Number lymphoid Percenfage of
Estrogen dosc of mice tumors lymphoid tumors
Estradiol benzoate 16.6 ,ug. 448 44 10
Estradiol benzoate 25 MAg. 340 30 9
Stilbestrol 250 Mg. 187 6 3
Estrone Pellet 105 19 18
Stilbestrol Pellet 1: 3* 135 48 36
Stilbestrol Pellet 1: 9t 6
Estradiol propionate 10 Mg. 18 1 5
Estradiol propionate 25 MAg. 50 6 12
Estradiol propionate 50 Ag. 114 9 8
Total 1403 165 11.7
*I1 part stilbestrol and 3 parts cholesterol
t I part stilbestrol and 9 parts cholesterol
plasia. The data do not indicate that one estrogenic chemical was
more effective in this particular carcinogenic stimulus than another.
Types of lymphomas among estrogen-treated hybrid and
control mice
The greater number of lymphoid tumors among both the con-
trol and the experimental animals were lymphomas similar to those
in mice of the pure straiins. Most of the animals had tumors that
apparently arose in the thymus and had infiltrated the adjacent
pericardium, heart, large blood vessels, esophagus, and lungs, and
often had invaded the intercostal musdes. Diffuse, or more rarely
nodular, metastases to the livers, spleens, lymph nodes, and the kid-
neys occurred in many of the animals. A number of the mice also
had a general infiltration of the adrenal glands, ovaries, and uteri.
Several ofthe mice had tumors composed primarily of mesenchy-
mal cells of the reticular tissues and were classified as reticulum-cell
sarcomas. In the animals bearing this type of tumor the extent of
the mediastinal involvement and the sites of metastases were similar
to those in the animals with the more usual types of lymphomas that
consisted predominantly of lymphoblastic or of small lymphocytic
cells. Sometimes it was difficult to ascertain whether or not hyper-
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plasias of the cells of the splenic and less frequently of the hepatic
reticular tissues in some of the treated animals were malignant. No
proliferations of the reticular cells were considered to be malignant
unless there were distinct and extensive metastases.
Several animals in groups resulting from the crosses between
the A and C57 strains of mice showed marked ectopic myelopoiesis.
Sometimes it was difficult to determine whether or not these myeloid
metaplasias were myelogenous leukemias. Many of them showed
a preponderance of immature myeloid cells but usually they showed
normoblastic cells as well. In none of the animals of the A7 groups,
however, were unquestionably leukemic myeloid lesions found.
One myelogenous leukemia was found among the control animals
of the JA group. In this mouse all ofthe hematopoietic organs were
grossly infiltrated by myeloid cells in all stages of differentiation.
Two other unusual tumors occurred in mice of the JA2 group.
These tumors were composed of mesenchymal cells and of cells of
the normoblastic series in all stages of differentiation. The normo-
blastic cells constituted the greater part of the large mediastinal
or thymic masses. The spleens, livers, kidneys, and mesenteric
lymph nodes were also extensively infiltrated with immature red
cells. Very few granulocytic elements of any type were found in
any of the sites at which these two tumors were observed.
Discussion
TEhe experiments reported here were undertaken essentially for
the purpose of studying the transmission of the tendency for mice to
acquire mammary, hypophyseal, and testicular tumors subsequent
to prolonged subjection to estrogens. It was known that estrogen-
treated mice of the A, C3H, and CBA strains acquired mammary
tumors,18 that similarly treated mice of the A and JK strains
acquired testicular tumors,10' 15 and that hypophyseal tumors
appeared frequently only among estrogen-treated mice of the C57
strain.14 The maternal transmission of the tendency to have mam-
mary tumors has been repeatedly demonstrated,2 and it has certainly
been partially confirmed in these experiments. The strain-limited
tendency for mice to acquire lymphoid tumors when exposed to pro-
longed treatment with effective amounts of estrogens was more
recently revealed.'2 Within the same species, therefore, the same
stimulus may result in the attainment of any one of several different
types of neoplasia.
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Both the male and female mice of the C57 strain when mated
with members of the CBA strain transmitted to their first generation
hybrid offspring the tendency to acquire hypophyseal tumors.9
The CBA mice simultaneously transmitted to the hybrid offspring
the tendency to acquire lymphoid tumors (table 3). However, the
female mice of the CBA strain predominantly transmitted the tend-
ency to have mammary tumors or precancerorus mammary hyper-
plasias when similarly treated as noted among the animals of the
CC2 group.9 Among the mice of this group mammary, lymphoid,
and hypophyseal tumors arose, whereas in the reciprocal group, that
is, among the CC1 group, only lymphoid and hypophyseal tumors
occurred.
The tendency for the estrogen-treated mice of the CC groups
to acquire hypophyseal tumors exceeded that of the susceptible
C57 strain,9' 14 probably because of the increased tolerance of the
hybrid animals to the estrogen and consequently their prolonged
survival. The incidence of lymphoid tumors was somewhat lower
(12 per cent) than that for the mice of the CBA strain (19 per cent)
subjected to similar treatment. In other words, the tendency to
acquire lymphoid tumors was intermediate between that of the two
parental strains. In this respect the susceptibility to estrogen-
induced leukemia was transmitted in a manner similar to the trans-
mission of spontaneous leukemia.22 The first generation hybrid
offspring obtained by mating mice of other strains with high and low
susceptibility to lymphoid tumors showed irregular tendencies to
acquire tumors or tended to resemble the susceptible strains."7 18
The average ages at which tumors appeared were greater among
the hybrid groups, however.3 18 Likewise, the average age of the
tumorous mice of the hybrid groups exceeded that of the total popu-
lation of each of the respective hybrid groups (table 5).
The incidences of lymphoid tumors of the hybrid mice obtained
bymating animals from other low-lymphoid-tumor strains with mice
of the high-tumor CBA or C3H strains were also intermediate
between the 2 parental groups, although in some the incidence was
slightly higher than in others.
The first generation hybrid young (A7 and JA groups) of the
strains (A, C57, and JK) which did not show lymphoid tumors sub-
sequent to estrogen treatment showed different incidences of tumors.
The A- groups had an incidence of tumors approximately the same
as that of the preceding hybrid groups with parents of the C3H or
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CBA strain, and the JA groups had no lymphoid tumors. On the
other hand, mice of 3 of the 4 hybrid groups showed a very high
incidence of spontaneous tumors. The incidence of spontaneous
tumors was greater than among the estrogen-treated mice. Tumors
among the control mice, however, appeared in old animals.
The results obtained with the first generation hybrid offspring
between mice of strains with contrasting susceptibilities to spontane-
ous or induced tumors have been sufficiently variable to prevent
extensive generalization. Although the present data are not too
extensive and some variability exists among the different groups
with respect to therelative incidence'of estrogen-induced lymphomas,
it is indicated that a genetic transmission exists for the tendency to
such neoplasia. In general, the tendency was transmitted equally by
both males and females of the susceptible strains. Furth et al., on
the other hand, observed a tendency for the hybrid young of sus-
ceptible X resistant parents to show a significantly lower incidence
of spontaneous leukemia when the dam was from the resistant
strain.7 The tendency for estrogen-induced leukemias among hybrid
mice, as among the mice of the pure strains, could not be associated
with the tendencyto acquire spontaneous tumors.
Theveryhigh incidence oflymphoid tumors among the estrogen-
treated hybrid young of the C3H X PM groups reveals an augment-
ing influence. At the same time that the incidence of tumors was
being so greatly increased among the treated animals, among the
controls the relative number of lymphomas was not appreciably
different from that in the parental strains. The longer survival of
the estrogen-treated hybrid mice might account for a part of the
elevated incidence of tumors. More hybrid mice, however, may
acquire mammary tumors than either of their parent strains when
maintained under similar conditions.' Similar tendencies have been
observed among hybrid mice in this laboratory.
The actions of estrogenic hormones on lymphoid tissues have
been discussed in a previous publication,12 and no significant addi-
tional information is available. The possibility that intrinsic estro-
gens may incite spontaneous leukemias has not been proved and
does not seem too plausible. However, among mice of several
strains or groups the number of lymphomas among the females
exceeds that amongthe males.7
Some strains of mice are much more susceptible than are others
to the development of lymphomas subsequent to the administration
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of carcinogens.5 19, 20, 23 It is not known, however, how transmitted
factors might alter the incidence in hybrid mice obtained by mating
animals susceptible to the carcinogen-induced lymphomas with non-
susceptible animals, or how estrogens might act in combination with
other leukemogenic agents. Carcinogens and roentgen rays may
augment the incidence of leukemia in a synergistic manner in mice
of some strains,6 but not of others.16 Animals showing a leukemo-
genic response to estrogen, however, do not necessarily show a simi-
lar response to the carcinogenic hydrocarbons.12' 19 Carcinogenic
hydrocarbons did not induce leukemia in mice of the C3H strain
whereas estrogens were effective.
The specificity of action of different agents in eliciting the same
neoplastic response in animals of different genetic groups is of con-
siderable interest. The possibility that a multiplicity of stimuli may
induce tumors of the same type in different animals will not simplify
the problem.
Summary
1. Hybrid mice of 16 different groups were either treated with
one of several different estrogenic chemicals or maintained as
untreated controls.
2. Of 1403 estrogen-treated mice 165, or approximately 12 per
cent, died with lymphoid tumors and 34, or 4.5 per cent, of 739
control mice died with tumors of the same type.
3. Hybrid mice born of parents of two strains susceptible to
estrogen-induced lymphomas had a high incidence of such tumors,
40 and 45 per cent, while no tumors occurred in the untreated
controls.
4. Hybrid mice born of parents one of which was susceptible
to estrogen-induced leukemia and one resistant showed incdences
intermediate between the parental stocks.
S. Hybrid mice born of parents from two strains resistant to
estrogen-induced leukemias had in one instance higher and in one
instance lower incidences of lymphomas than the parental strains.
6. The incidence of spontaneous lymphomas among the
untreated mice was high in three groups (11.5 to 20 per cent).
Among the mice of these groups the incidence of myeloid metaplasia
was also high and two mice showed erythroblastic neoplasia.
7. The lymphoid tumors were of the same types as described
as occurring among mice of the parental inbred strains.
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